首页> 中文期刊> 《中国循环杂志》 >抗血管紧张素Ⅱ 1型受体自身抗体与原发性高血压患者合并急性冠状动脉综合征发病风险的分析

抗血管紧张素Ⅱ 1型受体自身抗体与原发性高血压患者合并急性冠状动脉综合征发病风险的分析

         

摘要

Objective: To study the correlation between angiotensin II type1 receptor autoantibodies (AT1-AAs) and the onset risk in patients with essential hypertension (EH) combiningacute coronary syndrome (ACS). Methods: Our research included in 4 groups: EH+ACS group,n=28, ACS group, n=29, EH group,n=26 and Control group,n=23 normal subjects. Serum levels of AT1-AAs were examined by ELISA; high sensitivity C-reactive protein (hs-CRP), blood levels of lipids and glucose were also measured and compared among different groups. The correlations between AT1-AAs and blood lipids, glucose, hs-CRP were studied by multiple linear regression analysis. Results: Compared with Control group, ACS group had similar level of AT1-AAs (0.26±0.09) vs (0.21±0.06),P=0.105; while EH+ACS group and HE group had increased AT1-AAs level as (0.40±0.005) and (0.33±0.10),P=0.001 andP=0.02 respectively; AT1-AAs level was higher in EH+ACS group than HE group,P=0.044. In addition, serum AT1-AAs level was positively related to hs-CRP in EH+ACS group, ACS group and EH group (r=0.589,r=0.503 andr=0.273, allP<0.01). Conclusion: Serum AT1-AAs level was positively related to the onset risk in patients with EH combining ACS; AT1-AAs was also related to hs-CRP at certain degree.%目的:探讨抗血管紧张素II 1型(AT1)受体自身抗体(AT1-AAs)与原发性高血压患者合并急性冠状动脉综合征(ACS)的发病风险.方法:收集高血压合并ACS患者(高血压+ACS组)28例、单纯ACS患者(ACS组)29例、单纯高血压患者(高血压组)26例及正常对照组23例,采用酶联免疫吸附法对标本血清进行抗AT1受体抗体检测,分析并比较各组间AT1-AAs及血清超敏C反应蛋白(hs-CRP)、血脂、血糖等水平,进一步通过多元线性回归分析各组间AT1-AAs与血脂、血糖及炎症因子血清hs-CRP表达的相关性.结果:ACS组患者血清AT1-AAs水平较正常对照组升高(分别为0.26±0.09,0.21±0.06,P=0.105),但差异未达统计学意义;而高血压+ACS组(0.40±0.05)及高血压组(0.33±0.10)其血清AT1-AAs水平则显著高于正常对照组(P=0.01和0.02)同时高血压+ACS组也明显高于高血压组(P=0.044).另外,在除正常对照组外高血压+ACS组、ACS组及高血压组中AT1-AAs水平与血清hs-CRP的表达呈正相关(r分别为0.589、0.503、0.273,P均<0.01).结论:AT1-AAs与高血压合并ACS患者的发病风险呈正相关,尤其与炎症因子血清hs-CRP水平呈一定相关性.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号